Glenview Trust CO Novartis Ag Transaction History
Glenview Trust CO
- $5.68 Billion
- Q2 2025
A detailed history of Glenview Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Glenview Trust CO holds 3,800 shares of NVS stock, worth $465,918. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,800
Previous 3,716
2.26%
Holding current value
$465,918
Previous $414,000
10.87%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.31 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.11 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$927 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$873 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $264B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...